A Message from Paul V. Campanelli
Chief Executive Officer

I am very proud to have the extraordinary opportunity to serve as CEO of one of the most well respected and highly compliant pharmaceutical companies in the world. Joining Par in 2001 clearly represents the best decision I have ever made and it has been a privilege to work daily with so many dedicated colleagues. While we have achieved much over the past few years, I have little doubt that Par’s best days lie ahead.

We are excited to be the newest member of the TPG portfolio of well-known healthcare companies. TPG provides Par with greater flexibility to pursue its strategic goals. Importantly, TPG’s long-term orientation and access to capital will help support Par’s continued growth and success.

Our executive team remains as strong as ever, benefiting from its experience, integrity and trust of one another. Executive Chairman Patrick LePore, President Thomas Haughey, and CFO Michael Tropiano will continue to provide the leadership to which we are accustomed. I am extremely proud to be associated with each of them.

While Par’s ownership may have changed, its values and unique culture will endure. We will remain committed to service and quality as we continue to develop and manufacture cost effective Par generics and value-added proprietary products through our Strativa Pharmaceuticals division. By meeting the needs of our customers, partners, and the physicians and patients that rely upon us, Par will continue to be a respected industry leader. It will also continue to be a great place to work where, together, we will continue to accomplish great things.